z-logo
open-access-imgOpen Access
β-Adrenergic signaling in rat heart is similarly affected by continuous and intermittent normobaric hypoxia
Author(s) -
Klára Hahnová,
Dita Kašparová,
Jitka Žurmanová,
Jan Neckář,
František Kolář,
Jiřı́ Novotný
Publication year - 2016
Publication title -
general physiology and biophysics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.376
H-Index - 39
eISSN - 1338-4325
pISSN - 0231-5882
DOI - 10.4149/gpb_2015053
Subject(s) - hypoxia (environmental) , adenylyl cyclase , adrenergic , medicine , endocrinology , adrenergic receptor , cardioprotection , receptor , pharmacology , biology , ischemia , chemistry , oxygen , organic chemistry
Chronic hypoxia may produce a cardioprotective phenotype characterized by increased resistance to ischemia-reperfusion injury. Nevertheless, the molecular basis of cardioprotective effects of hypoxia is still not quite clear. The present study investigated the consequences of a 3-week adaptation to cardioprotective (CNH, continuous normobaric hypoxia) and nonprotective (INH, intermittent normobaric hypoxia; 23 h/day hypoxia followed by 1 h/day reoxygenation) regimen of hypoxia on β-adrenergic signaling in the rat myocardium. Both regimens of hypoxia lowered body weight and led to marked right ventricular (RV) hypertrophy, which was accompanied by 25% loss of β1-adrenergic receptors (β1-ARs) in the RV. No significant changes were found in β-ARs in left ventricular (LV) preparations from animals adapted to hypoxia. Although adenylyl cyclase (AC) activity stimulated through the G proteins was decreased in the RV and increased in the LV after exposure to hypoxia, there were no significant changes in the expression of the dominant myocardial AC 5/6 isoforms and the stimulatory G proteins. These data suggest that chronic normobaric hypoxia may strongly affect myocardial β-adrenergic signaling but adaptation to cardioprotective and nonprotective regimens of hypoxia does not cause notably diverse changes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here